COVID-19 vaccine CPT codes published by AMA

COVID-19 vaccine CPT codes published by AMA

The American Medical Association has published a host of new CPT codes to cover the yet-to-be-released COVID-19 vaccine.

Codes for two vaccines were announced earlier this week after receiving approval. Their long descriptions are as follows:

  • 91300: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3mL dosage, diluent reconstituted, for intramuscular use
  • 91301: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5mL dosage, for intramuscular use

Additionally, the codes were accompanied by unique administration codes that will allow for tracking a reporting of vaccine doses. These codes will also cover counseling offered to the patient and will serve to update their health records.

  • 0001A: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3mL dosage, diluent reconstituted; first dose
  • 0002A: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3mL dosage, diluent reconstituted; second dose
  • 0011A: Immunization administration by intramuscular injection of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5mL dosage; first dose
  • 0012A: Immunization administration by intramuscular injection of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5mL dosage; second dose

The AMA said the codes will go into effect once a vaccine is approved or receives an EUA.

Last month, CMS established a reimbursement rate of $28.39 for the administration of the vaccine in anticipation of the publication of these new codes. If a COVID-19 vaccine requires multiple doses, CMS said it will reimburse providers $16.94 for the initial doses and $28.39 for the administration of the final dose in the series.

CMS has also said the vaccine must be made available to all patients at no cost. The agency is requiring almost all plans to waive any cost-sharing requirements and preventing providers from balance-billing for the service. Providers will be reimbursed via the Uninsured Program Portal when treating uninsured patients.